Screening and Prevention of Preeclampsia
Abstract. Preeclampsia (PE) is a multisystem disorder of pregnancy classically characterized by hypertension with significant proteinuria after 20 weeks' gestation. This disorder is one of the leading causes of maternal and perinatal morbidity and mortality. PE can be subdivided into preterm PE...
Saved in:
Main Authors: | Liona C. Poon (Author), Daljit Sahota (Author), Yan-Li Li (Author), Yang Pan (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Health,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First Trimester Screening for Preeclampsia: An Asian Perspective
by: Sakita Moungmaithong, et al.
Published: (2021) -
How Different Are Diverse Populations in Screening for Preeclampsia?
by: Raigam Jafet Martinez-Portilla, et al.
Published: (2021) -
Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population
by: Smriti Prasad, et al.
Published: (2021) -
How can we reduce neonatal sepsis after universal group B streptococcus screening?
by: Tak Yuen Fung, et al.
Published: (2024) -
Preeclampsia: Universal Screening or Universal Prevention for Low andMiddle-Income Settings?
by: Daniel Lorber Rolnik, et al.
Published: (2021)